193 related articles for article (PubMed ID: 19657585)
1. Immunohistochemical analysis of brain lesions using S100B and glial fibrillary acidic protein antibodies in arundic acid- (ONO-2506) treated stroke-prone spontaneously hypertensive rats.
Higashino H; Niwa A; Satou T; Ohta Y; Hashimoto S; Tabuchi M; Ooshima K
J Neural Transm (Vienna); 2009 Oct; 116(10):1209-19. PubMed ID: 19657585
[TBL] [Abstract][Full Text] [Related]
2. Arundic acid administration protects astrocytes, recovers histological damage and memory deficits induced by neonatal hypoxia ischemia in rats.
Mari C; Odorcyk FK; Sanches EF; Wartchow KM; Martini AP; Nicola F; Zanotto C; Wyse AT; Gonçalves CA; Netto CA
Int J Dev Neurosci; 2019 Aug; 76():41-51. PubMed ID: 31202867
[TBL] [Abstract][Full Text] [Related]
3. Arundic acid (ONO-2506) downregulates neuroinflammation and astrocyte dysfunction after status epilepticus in young rats induced by Li-pilocarpine.
Vizuete AFK; Leal MB; Moreira AP; Seady M; Taday J; Gonçalves CA
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Apr; 123():110704. PubMed ID: 36565981
[TBL] [Abstract][Full Text] [Related]
4. Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B.
Asano T; Mori T; Shimoda T; Shinagawa R; Satoh S; Yada N; Katsumata S; Matsuda S; Kagamiishi Y; Tateishi N
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):127-42. PubMed ID: 15857298
[TBL] [Abstract][Full Text] [Related]
5. Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice.
Oki C; Watanabe Y; Yokoyama H; Shimoda T; Kato H; Araki T
Cell Mol Neurobiol; 2008 May; 28(3):417-30. PubMed ID: 18204968
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of glial fibrillary acidic protein in the brain of spontaneously hypertensive rats.
Tomassoni D; Avola R; Di Tullio MA; Sabbatini M; Vitaioli L; Amenta F
Clin Exp Hypertens; 2004 May; 26(4):335-50. PubMed ID: 15195688
[TBL] [Abstract][Full Text] [Related]
7. PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation.
Roltsch E; Holcomb L; Young KA; Marks A; Zimmer DB
J Neuroinflammation; 2010 Nov; 7():78. PubMed ID: 21080947
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.
Simpson JE; Ince PG; Lace G; Forster G; Shaw PJ; Matthews F; Savva G; Brayne C; Wharton SB;
Neurobiol Aging; 2010 Apr; 31(4):578-90. PubMed ID: 18586353
[TBL] [Abstract][Full Text] [Related]
9. Amyloid β-peptide directly induces spontaneous calcium transients, delayed intercellular calcium waves and gliosis in rat cortical astrocytes.
Chow SK; Yu D; Macdonald CL; Buibas M; Silva GA
ASN Neuro; 2010 Jan; 2(1):e00026. PubMed ID: 20001968
[TBL] [Abstract][Full Text] [Related]
10. Modulation of astrocytic activation by arundic acid (ONO-2506) mitigates detrimental effects of the apolipoprotein E4 isoform after permanent focal ischemia in apolipoprotein E knock-in mice.
Mori T; Town T; Tan J; Tateishi N; Asano T
J Cereb Blood Flow Metab; 2005 Jun; 25(6):748-62. PubMed ID: 15689951
[TBL] [Abstract][Full Text] [Related]
11. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E.
Baydas G; Nedzvetskii VS; Tuzcu M; Yasar A; Kirichenko SV
Eur J Pharmacol; 2003 Feb; 462(1-3):67-71. PubMed ID: 12591097
[TBL] [Abstract][Full Text] [Related]
12. Arundic acid (ONO-2526) inhibits stimulated-S100B secretion in inflammatory conditions.
Vizuete AFK; de Lima Cordeiro J; Neves JD; Seady M; Grun LK; Barbé-Tuana FM; Leite MC; Netto CA; Gonçalves CA
Neurosci Lett; 2021 Apr; 751():135776. PubMed ID: 33727126
[TBL] [Abstract][Full Text] [Related]
13. Expression of S100 protein and protective effect of arundic acid on the rat brain in chronic cerebral hypoperfusion.
Ohtani R; Tomimoto H; Wakita H; Kitaguchi H; Nakaji K; Takahashi R
Brain Res; 2007 Mar; 1135(1):195-200. PubMed ID: 17210147
[TBL] [Abstract][Full Text] [Related]
14. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
Kato H; Kurosaki R; Oki C; Araki T
Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats.
Tayebati SK; Di Tullio MA; Tomassoni D; Amenta F
J Neurol Sci; 2009 Aug; 283(1-2):187-94. PubMed ID: 19304299
[TBL] [Abstract][Full Text] [Related]
16. Effects of arundic acid, an astrocytic modulator, on the cerebral and respiratory functions in severe hypoxia.
Fukushi I; Takeda K; Yokota S; Hasebe Y; Sato Y; Pokorski M; Horiuchi J; Okada Y
Respir Physiol Neurobiol; 2016 Jun; 226():24-9. PubMed ID: 26592145
[TBL] [Abstract][Full Text] [Related]
17. S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation.
Steiner J; Bernstein HG; Bogerts B; Gos T; Richter-Landsberg C; Wunderlich MT; Keilhoff G
Neuroscience; 2008 Jun; 154(2):496-503. PubMed ID: 18472341
[TBL] [Abstract][Full Text] [Related]
18. Vascular and neuronal hypertensive brain damage: protective effect of treatment with nicardipine.
Amenta F; Strocchi P; Sabbatini M
J Hypertens Suppl; 1996 Oct; 14(3):S29-35. PubMed ID: 9120663
[TBL] [Abstract][Full Text] [Related]
19. Arundic Acid (ONO-2506), an Inhibitor of S100B Protein Synthesis, Prevents Neurological Deficits and Brain Tissue Damage Following Intracerebral Hemorrhage in Male Wistar Rats.
Cordeiro JL; Neves JD; Vizuete AF; Aristimunha D; Pedroso TA; Sanches EF; Gonçalves CA; Netto CA
Neuroscience; 2020 Aug; 440():97-112. PubMed ID: 32474054
[TBL] [Abstract][Full Text] [Related]
20. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology.
Pinto SS; Gottfried C; Mendez A; Gonçalves D; Karl J; Gonçalves CA; Wofchuk S; Rodnight R
FEBS Lett; 2000 Dec; 486(3):203-7. PubMed ID: 11119704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
